QUINORA Drug Patent Profile
When do Quinora patents expire, and what generic alternatives are available?
Quinora is a drug marketed by Key Pharms and Schering and is included in two NDAs.
The generic ingredient in QUINORA is quinidine sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the quinidine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinora
A generic version of QUINORA was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUINORA?
- What are the global sales for QUINORA?
- What is Average Wholesale Price for QUINORA?
Summary for QUINORA
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4,320 |
| DailyMed Link: | QUINORA at DailyMed |
US Patents and Regulatory Information for QUINORA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Pharms | QUINORA | quinidine sulfate | TABLET;ORAL | 083576-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Schering | QUINORA | quinidine sulfate | TABLET;ORAL | 085222-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
